|
gptkbp:instance_of
|
gptkb:Company
|
|
gptkbp:bfsLayer
|
2
|
|
gptkbp:bfsParent
|
gptkb:physicist
|
|
gptkbp:acquisition
|
gptkb:Nant_Cell
none reported
|
|
gptkbp:advocates_for
|
support groups
|
|
gptkbp:business_model
|
gptkb:drug
|
|
gptkbp:ceo
|
gptkb:Patrick_Soon-Shiong
|
|
gptkbp:clinical_trial
|
gptkb:healthcare_organization
hospitals
Phase 1
Phase 2
Phase 3
various cancer treatments
overall survival
progression-free survival
patient trials
safety profiles
biotech company
|
|
gptkbp:collaborations
|
academic institutions
research institutions
biopharmaceuticals
|
|
gptkbp:committee
|
experts
|
|
gptkbp:employees
|
approximately 100
|
|
gptkbp:focus
|
gptkb:vaccine
|
|
gptkbp:founded
|
gptkb:2015
|
|
gptkbp:founder
|
gptkb:Patrick_Soon-Shiong
|
|
gptkbp:headcount
|
employees
|
|
gptkbp:headquarters
|
gptkb:Culver_City,_California
|
|
gptkbp:healthcare
|
cancer immunotherapy
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Nant Kwest
|
|
gptkbp:innovation
|
cancer therapies
|
|
gptkbp:investment
|
gptkb:Company
biotech sector
|
|
gptkbp:language_of_instruction
|
therapeutic candidates
|
|
gptkbp:leadership
|
biotech executives
|
|
gptkbp:market
|
oncology
|
|
gptkbp:marketing_strategy
|
global expansion
innovation-driven
|
|
gptkbp:mission
|
transform cancer treatment
|
|
gptkbp:partnership
|
gptkb:Nant_Works
|
|
gptkbp:partnerships
|
pharmaceutical companies
various pharmaceutical companies
clinical collaborations
|
|
gptkbp:platform
|
NK cell therapy
|
|
gptkbp:population
|
cancer patients
|
|
gptkbp:publishes
|
peer-reviewed journals
|
|
gptkbp:receives_funding_from
|
grants
public offerings
|
|
gptkbp:regulatory_body
|
drug candidates
|
|
gptkbp:regulatory_compliance
|
gptkb:FDA
clinical data
|
|
gptkbp:research
|
cancer biology
translational medicine
|
|
gptkbp:research_and_development
|
biologics
|
|
gptkbp:research_areas
|
gptkb:NK-92_cells
immuno-oncology
novel therapies
immune modulation
|
|
gptkbp:research_focus
|
solid tumors
cancer immunotherapy
cell-based therapies
|
|
gptkbp:stock_exchange
|
gptkb:NASDAQ
gptkb:battle
|
|
gptkbp:symbol
|
NK
|
|
gptkbp:technology
|
natural killer cells
natural killer cell therapy
competitive environment
|
|
gptkbp:traded_on
|
gptkb:NASDAQ
|
|
gptkbp:treatment
|
treatment efficacy
|
|
gptkbp:vision
|
personalized medicine
|
|
gptkbp:website
|
www.nantkwest.com
|